At Invetx, we bring the best of biopharma to animal health.
We are building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics.
Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, we are focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care.
Our network includes experts in both animal and human health, veterinary scientists and clinicians. Our vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.
You will also be able to hear from us on Twitter at @invetx.
Company Details
- Employees
- 13
- Address
- Boston, Ma, Us
- in****@****etx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- invetx.com
- HQ
- Boston, MA
Invetx - A Dechra Division Questions
Invetx - A Dechra Division's website is invetx.com
Invetx - A Dechra Division's LinkedIn profile is https://www.linkedin.com/company/invetx
Invetx - A Dechra Division has
13 employees.
View email and phone details for 13
employees at Invetx - A Dechra Division.
Invetx - A Dechra Division's industry is
Biotechnology Research
Invetx - A Dechra Division's top competitors are
Boehringer Ingelheim,
Dechra,
Anterra Capital,
Ceva Sante Animale,
Crosswalk Therapeutics,
Virbac,
Zoetis,
Animol Discovery, Inc.,
Covetrus,
Vetmab Biosciences, Inc..
Invetx - A Dechra Division's support email address is info@invetx.com
Invetx - A Dechra Division's categories are Biotechnology Research
